2026 Could Be a Big Year for Viking Therapeutics. Time to Buy?

2026 Could Be a Big Year for Viking Therapeutics. Time to Buy?

Key PointsViking Therapeutics is working to join a market that may be worth almost $100 billion in just a few years.The company is studying a candidate for weight loss in late-stage trials.10 stocks we like better than Viking Therapeutics › Viking Therapeutics (NASDAQ: VKTX) is aiming to join one of the biggest growth industries of the times: the weight loss drug market. People hoping to lose weight have rushed to get in on GLP-1 drugs, a type o…